Spirox is committed to improving the quality of life for patients suffering from nasal obstruction, a condition that affects more than 20 million individuals in the United States. The Menlo Park-based company’s first product—the LATERA absorbable nasal implant—is designed to address one of the most common, yet undertreated, causes of nasal obstruction today, nasal valve collapse (NVC). For more information, please visit www.spiroxmed.com. LATERA is available in the U.S. only. Spirox and LATERA and its logos are trademarks of Spirox, Inc.
View Top Employees from Spirox, Inc.| Website | https://www.spiroxmed.com |
| Revenue | $9.4 million |
| Funding | $69.7 million |
| Employees | 34 (3 on RocketReach) |
| Founded | 2012 |
| Address | 595 Penobscot Dr, Redwood City, California 94063, US |
| Phone | (650) 487-2203 |
| Technologies |
JavaScript,
HTML,
Nginx
+14 more
(view full list)
|
| Industry | Medical Device, Medical Devices, Consumer Services General, Biotechnology, Plastics, Consumer Services, Science and Engineering, Medical, Health Care |
| Competitors | Entellus Medical, Inc., Now a Part of Stryker, Intersect ENT, Inc., Now Part of Medtronic, S.T.Stent, SinuSys Corp. |
| SIC | SIC Code 38 Companies, SIC Code 384 Companies |
Looking for a particular Spirox, Inc. employee's phone or email?
Spirox, Inc. Questions
The Spirox, Inc. annual revenue was $9.4 million in 2024.
3 people are employed at Spirox, Inc..
Spirox, Inc. is based in Redwood City, California.
The SIC codes for Spirox, Inc. are [38, 384].
Related Companies
